Clene (CLNN) Director Kiernan Matthew Receives Stock Option Award

What Happened
Kiernan Matthew, a director of Clene Inc. (CLNN), was granted a stock option award for 3,195 shares of common stock on August 13, 2026. The options carry an exercise price of $4.19 per share (aggregate exercise cost ≈ $13,387) and vest immediately upon grant. This filing reports a derivative acquisition (grant), not an open‑market purchase or sale.

Key Details

• Transaction date: August 13, 2026; filing date: August 14, 2026 (Accession: 0001437749-26-027973).
• Transaction type/code: Grant/Award (derivative) — code A.
• Award: Options for 3,195 shares at $4.19 exercise price (total strike ≈ $13,387.05).
• Vesting: Options vest immediately (per footnote).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Timeliness: Report filed the day after the grant; not marked late in the provided data.

Context
This was an option grant (a derivative award), not an exercise or sale — the director received the right to buy shares at $4.19 each in the future. Immediate vesting means the options can be exercised right away subject to plan terms. Option grants increase potential future insider ownership if exercised but do not represent an immediate purchase of shares or a cash inflow/outflow until exercised.